Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy (Q48267220)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 June 2014

Language	Label	Description	Also known as
English	Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy	scientific article published on 24 June 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

Domenico Britti

6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

Giovambattista De Sarro

7

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

8

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

author name string

Serafina Chimirri

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

Rossana Aiello

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

Luca Gallelli

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

Francesca Trimboli

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

publication date

24 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

55

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

8

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

1284-1291

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

The role of inflammation in epileptogenesis

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Mechanisms of epileptogenesis and potential treatment targets

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Antiepileptogenic agents: how close are we?

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Molecular cascades that mediate the influence of inflammation on epilepsy

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Mechanisms and clinical evidence of the pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in central nervous system disorders: a comprehensive review

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Statins in neurological disorders: mechanisms and therapeutic value.

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Lovastatin decreases the synthesis of inflammatory mediators in the hippocampus and blocks the hyperthermia of rats submitted to long-lasting status epilepticus

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Administration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Lovastatin exacerbates atypical absence seizures with only minimal effects on brain sterols.

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Statin use and risk of epilepsy: a nested case-control study

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

The WAG/Rij strain: A genetic animal model of absence epilepsy with comorbidity of depressiony

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

The relationship between statins and depression: a review of the literature

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Animal models of neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Bi-lateral changes to hippocampal cholesterol levels during epileptogenesis and in chronic epilepsy following focal-onset status epilepticus in mice.

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

CNS synaptogenesis promoted by glia-derived cholesterol

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Changes in brain cholesterol metabolome after excitotoxicity.

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Premature mortality in people with epilepsy in rural China: a prospective study

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

IL-1β is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Effects of neurosteroids on spike-wave discharges in the genetic epileptic WAG/Rij rat.

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Acute atorvastatin treatment exerts antidepressant-like effect in mice via the L-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Protective effect of HMG CoA reductase inhibitors against running wheel activity induced fatigue, anxiety like behavior, oxidative stress and mitochondrial dysfunction in mice

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Statins may enhance the proteolytic cleavage of proBDNF: implications for the treatment of depression

1 reference

https://api.crossref.org/works/10.1111/EPI.12686

21 January 2018

Identifiers

10.1111/EPI.12686

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24962151

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48267220&oldid=2193449828"